Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 59 | 2024 | 1204 | 11.770 |
Why?
|
Breast Implants | 25 | 2024 | 387 | 8.750 |
Why?
|
Breast Implantation | 17 | 2023 | 218 | 5.910 |
Why?
|
Nipples | 17 | 2024 | 219 | 4.490 |
Why?
|
Mastectomy, Subcutaneous | 10 | 2021 | 46 | 3.860 |
Why?
|
Mastectomy | 35 | 2024 | 1793 | 3.040 |
Why?
|
Breast Neoplasms | 50 | 2024 | 20827 | 2.510 |
Why?
|
Surgery, Plastic | 5 | 2023 | 624 | 2.200 |
Why?
|
Cicatrix | 12 | 2022 | 763 | 1.830 |
Why?
|
Tissue Expansion Devices | 11 | 2022 | 156 | 1.570 |
Why?
|
Surgical Flaps | 15 | 2020 | 1629 | 1.570 |
Why?
|
Tissue Expansion | 7 | 2016 | 162 | 1.160 |
Why?
|
Postoperative Complications | 21 | 2024 | 15281 | 1.150 |
Why?
|
Breast | 8 | 2023 | 1970 | 1.140 |
Why?
|
Wound Healing | 11 | 2018 | 2776 | 0.970 |
Why?
|
Surgical Wound Infection | 6 | 2020 | 1539 | 0.910 |
Why?
|
Silicone Gels | 2 | 2021 | 39 | 0.890 |
Why?
|
Collagen | 7 | 2011 | 2681 | 0.880 |
Why?
|
Transforming Growth Factor beta | 6 | 2007 | 2006 | 0.840 |
Why?
|
Hernia, Umbilical | 1 | 2023 | 96 | 0.840 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 8 | 2019 | 948 | 0.840 |
Why?
|
Smad Proteins | 3 | 2007 | 162 | 0.830 |
Why?
|
Skin | 10 | 2022 | 4372 | 0.810 |
Why?
|
Journal Impact Factor | 1 | 2022 | 155 | 0.770 |
Why?
|
Fibroblasts | 5 | 2007 | 4162 | 0.660 |
Why?
|
Fetus | 8 | 2007 | 1880 | 0.640 |
Why?
|
Hypertrophy | 1 | 2019 | 569 | 0.580 |
Why?
|
Intraoperative Complications | 2 | 2015 | 1195 | 0.560 |
Why?
|
Intermittent Pneumatic Compression Devices | 2 | 2012 | 25 | 0.550 |
Why?
|
Necrosis | 7 | 2023 | 1642 | 0.550 |
Why?
|
Retrospective Studies | 39 | 2024 | 77410 | 0.540 |
Why?
|
Spectroscopy, Near-Infrared | 3 | 2011 | 717 | 0.530 |
Why?
|
Weight Loss | 5 | 2010 | 2625 | 0.520 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.510 |
Why?
|
Abdominal Muscles | 2 | 2019 | 166 | 0.510 |
Why?
|
Buttocks | 2 | 2022 | 110 | 0.500 |
Why?
|
Female | 78 | 2024 | 380020 | 0.490 |
Why?
|
Standard of Care | 1 | 2018 | 564 | 0.470 |
Why?
|
Venous Thrombosis | 2 | 2012 | 1240 | 0.440 |
Why?
|
Cosmetic Techniques | 1 | 2015 | 135 | 0.440 |
Why?
|
Perioperative Care | 2 | 2012 | 1002 | 0.440 |
Why?
|
Keratinocytes | 2 | 2007 | 796 | 0.440 |
Why?
|
Humans | 92 | 2024 | 743811 | 0.440 |
Why?
|
Biocompatible Materials | 3 | 2011 | 1731 | 0.440 |
Why?
|
Body Image | 3 | 2022 | 610 | 0.430 |
Why?
|
Pheochromocytoma | 1 | 2015 | 337 | 0.420 |
Why?
|
Reoperation | 7 | 2021 | 4200 | 0.370 |
Why?
|
Umbilicus | 1 | 2010 | 41 | 0.360 |
Why?
|
Mastectomy, Modified Radical | 1 | 2009 | 62 | 0.350 |
Why?
|
Thrombin | 1 | 2012 | 598 | 0.350 |
Why?
|
Bariatric Surgery | 2 | 2010 | 952 | 0.350 |
Why?
|
Prenatal Injuries | 2 | 2008 | 13 | 0.340 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 740 | 0.340 |
Why?
|
Abdominal Wall | 1 | 2010 | 157 | 0.330 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 2017 | 1100 | 0.320 |
Why?
|
Somatotypes | 1 | 2008 | 42 | 0.320 |
Why?
|
Abdominal Fat | 1 | 2010 | 223 | 0.320 |
Why?
|
Middle Aged | 47 | 2022 | 213241 | 0.320 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2022 | 1770 | 0.310 |
Why?
|
Surface Properties | 2 | 2021 | 1168 | 0.310 |
Why?
|
Algorithms | 4 | 2021 | 13869 | 0.310 |
Why?
|
Oximetry | 2 | 2008 | 471 | 0.300 |
Why?
|
Antibiotic Prophylaxis | 1 | 2012 | 638 | 0.300 |
Why?
|
Prosthesis-Related Infections | 1 | 2013 | 537 | 0.300 |
Why?
|
Adult | 45 | 2022 | 213889 | 0.290 |
Why?
|
Staphylococcal Infections | 2 | 2013 | 1400 | 0.280 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2006 | 59 | 0.280 |
Why?
|
Salvage Therapy | 1 | 2013 | 1275 | 0.280 |
Why?
|
Treatment Outcome | 23 | 2022 | 63042 | 0.270 |
Why?
|
Immediate-Early Proteins | 2 | 2006 | 453 | 0.270 |
Why?
|
Esthetics | 2 | 2023 | 305 | 0.270 |
Why?
|
Wounds, Penetrating | 1 | 2008 | 307 | 0.270 |
Why?
|
Adipose Tissue | 2 | 2008 | 3280 | 0.270 |
Why?
|
Mice, Inbred BALB C | 7 | 2008 | 6380 | 0.260 |
Why?
|
Sodium Chloride | 3 | 2016 | 625 | 0.260 |
Why?
|
Heparin | 1 | 2012 | 1637 | 0.260 |
Why?
|
Fetal Organ Maturity | 1 | 2005 | 82 | 0.260 |
Why?
|
Ear, External | 1 | 2006 | 161 | 0.260 |
Why?
|
Replantation | 1 | 2006 | 148 | 0.250 |
Why?
|
Fetal Proteins | 1 | 2005 | 94 | 0.250 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2005 | 79 | 0.250 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 369 | 0.250 |
Why?
|
Incidence | 9 | 2022 | 20948 | 0.250 |
Why?
|
Breast Diseases | 1 | 2008 | 443 | 0.240 |
Why?
|
Prosthesis Design | 2 | 2021 | 2103 | 0.240 |
Why?
|
Follow-Up Studies | 15 | 2022 | 39001 | 0.240 |
Why?
|
Staphylococcus aureus | 1 | 2012 | 1453 | 0.240 |
Why?
|
Dermatomycoses | 1 | 2004 | 45 | 0.240 |
Why?
|
Scalp Dermatoses | 1 | 2004 | 40 | 0.240 |
Why?
|
Collagen Type I | 1 | 2007 | 592 | 0.230 |
Why?
|
Groin | 1 | 2004 | 105 | 0.230 |
Why?
|
Carbon Dioxide | 3 | 2016 | 1150 | 0.230 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 2123 | 0.220 |
Why?
|
Carcinoma, Lobular | 3 | 2016 | 484 | 0.220 |
Why?
|
Lipectomy | 2 | 2017 | 119 | 0.220 |
Why?
|
Fingers | 1 | 2006 | 513 | 0.220 |
Why?
|
Growth Substances | 1 | 2005 | 784 | 0.210 |
Why?
|
Lung Diseases, Fungal | 1 | 2003 | 122 | 0.210 |
Why?
|
Patient Selection | 4 | 2017 | 4210 | 0.210 |
Why?
|
Wnt Proteins | 1 | 2006 | 721 | 0.210 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 547 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 552 | 0.200 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1869 | 0.200 |
Why?
|
Medical Device Recalls | 1 | 2021 | 16 | 0.200 |
Why?
|
Thigh | 1 | 2022 | 247 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2006 | 1678 | 0.200 |
Why?
|
Incidental Findings | 2 | 2018 | 689 | 0.200 |
Why?
|
Carotid Body Tumor | 1 | 2001 | 32 | 0.200 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2001 | 46 | 0.200 |
Why?
|
Aspergillosis | 1 | 2003 | 235 | 0.190 |
Why?
|
Sarcoma, Synovial | 1 | 2002 | 167 | 0.190 |
Why?
|
Fetal Diseases | 1 | 2006 | 903 | 0.190 |
Why?
|
Anti-Bacterial Agents | 3 | 2016 | 7172 | 0.190 |
Why?
|
Postoperative Care | 3 | 2019 | 1485 | 0.190 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2008 | 1524 | 0.190 |
Why?
|
Anticoagulants | 2 | 2012 | 4599 | 0.180 |
Why?
|
Body Patterning | 1 | 2005 | 629 | 0.180 |
Why?
|
Nomograms | 1 | 2022 | 228 | 0.180 |
Why?
|
Certification | 1 | 2023 | 423 | 0.180 |
Why?
|
Australia | 1 | 2023 | 1167 | 0.180 |
Why?
|
Contracture | 1 | 2022 | 223 | 0.180 |
Why?
|
Peer Review, Research | 1 | 2022 | 329 | 0.170 |
Why?
|
Wounds and Injuries | 3 | 2006 | 2401 | 0.170 |
Why?
|
Obesity, Morbid | 1 | 2010 | 1213 | 0.170 |
Why?
|
Skin, Artificial | 2 | 2010 | 90 | 0.170 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3622 | 0.170 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 169 | 0.170 |
Why?
|
Combined Modality Therapy | 5 | 2022 | 8637 | 0.170 |
Why?
|
Aged | 24 | 2022 | 163178 | 0.170 |
Why?
|
Medical Oncology | 2 | 2022 | 2267 | 0.160 |
Why?
|
Time Factors | 7 | 2019 | 40038 | 0.160 |
Why?
|
Risk Assessment | 6 | 2022 | 23327 | 0.160 |
Why?
|
Transforming Growth Factor beta1 | 3 | 2006 | 644 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 552 | 0.160 |
Why?
|
Mediastinal Neoplasms | 1 | 2001 | 423 | 0.150 |
Why?
|
Pleural Neoplasms | 1 | 2002 | 608 | 0.150 |
Why?
|
Gestational Age | 4 | 2007 | 3488 | 0.150 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 1351 | 0.150 |
Why?
|
Face | 1 | 2023 | 993 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2019 | 203 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2001 | 604 | 0.150 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 202 | 0.150 |
Why?
|
Smad7 Protein | 2 | 2007 | 41 | 0.140 |
Why?
|
Immunologic Factors | 1 | 2006 | 1580 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12243 | 0.140 |
Why?
|
Prospective Studies | 10 | 2022 | 53250 | 0.140 |
Why?
|
Propensity Score | 1 | 2023 | 1781 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 687 | 0.140 |
Why?
|
Device Removal | 1 | 2021 | 655 | 0.130 |
Why?
|
Connective Tissue Growth Factor | 2 | 2006 | 96 | 0.130 |
Why?
|
Regeneration | 1 | 2005 | 1486 | 0.130 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 1670 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9239 | 0.130 |
Why?
|
Rare Diseases | 1 | 2020 | 552 | 0.130 |
Why?
|
Patient Satisfaction | 5 | 2021 | 3391 | 0.130 |
Why?
|
History, 21st Century | 1 | 2021 | 1532 | 0.120 |
Why?
|
Hypertension | 1 | 2015 | 8480 | 0.120 |
Why?
|
Centrifugation | 1 | 2014 | 122 | 0.120 |
Why?
|
Cells, Cultured | 5 | 2008 | 19232 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2006 | 4552 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3510 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1639 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 950 | 0.110 |
Why?
|
Hospitals, General | 1 | 2017 | 749 | 0.110 |
Why?
|
Pectoralis Muscles | 2 | 2018 | 82 | 0.110 |
Why?
|
Antisepsis | 1 | 2012 | 18 | 0.110 |
Why?
|
Polymerase Chain Reaction | 3 | 2008 | 6170 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2022 | 57744 | 0.110 |
Why?
|
History, 20th Century | 1 | 2021 | 2736 | 0.110 |
Why?
|
Postpartum Period | 1 | 2019 | 1086 | 0.110 |
Why?
|
Dalteparin | 1 | 2012 | 42 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2950 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9440 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2001 | 1332 | 0.100 |
Why?
|
Animals, Newborn | 2 | 2007 | 2725 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2015 | 491 | 0.100 |
Why?
|
Young Adult | 10 | 2022 | 56392 | 0.100 |
Why?
|
Perioperative Period | 1 | 2012 | 256 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1582 | 0.090 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2012 | 339 | 0.090 |
Why?
|
Disinfection | 1 | 2012 | 191 | 0.090 |
Why?
|
Cyanoacrylates | 1 | 2010 | 49 | 0.090 |
Why?
|
Costs and Cost Analysis | 2 | 2015 | 1680 | 0.090 |
Why?
|
Cohort Studies | 3 | 2023 | 40545 | 0.090 |
Why?
|
Seroma | 2 | 2020 | 71 | 0.090 |
Why?
|
Sarcoma | 1 | 2001 | 1898 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2727 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1642 | 0.090 |
Why?
|
Animals | 12 | 2014 | 168660 | 0.080 |
Why?
|
Lymphedema | 1 | 2016 | 534 | 0.080 |
Why?
|
Regression Analysis | 1 | 2019 | 6457 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 956 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 409 | 0.080 |
Why?
|
Tissue Adhesives | 1 | 2010 | 179 | 0.080 |
Why?
|
Bandages | 1 | 2010 | 266 | 0.080 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4925 | 0.080 |
Why?
|
Mice | 8 | 2014 | 81154 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2274 | 0.080 |
Why?
|
Body Mass Index | 3 | 2013 | 12718 | 0.080 |
Why?
|
Massachusetts | 2 | 2018 | 8660 | 0.080 |
Why?
|
Graft Survival | 2 | 2016 | 3734 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 985 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3476 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7270 | 0.080 |
Why?
|
Adipocytes | 1 | 2014 | 1182 | 0.080 |
Why?
|
Sutures | 1 | 2009 | 299 | 0.070 |
Why?
|
Skin Physiological Phenomena | 1 | 2008 | 180 | 0.070 |
Why?
|
Registries | 1 | 2023 | 8090 | 0.070 |
Why?
|
Sterilization | 1 | 2008 | 133 | 0.070 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3677 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1459 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 12066 | 0.070 |
Why?
|
Smad4 Protein | 1 | 2007 | 163 | 0.070 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2006 | 44 | 0.070 |
Why?
|
Enzyme Induction | 1 | 2006 | 475 | 0.070 |
Why?
|
Ultrasonography, Doppler | 1 | 2008 | 458 | 0.070 |
Why?
|
Smad3 Protein | 1 | 2006 | 180 | 0.070 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2006 | 158 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1620 | 0.070 |
Why?
|
Keloid | 1 | 2005 | 50 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4398 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11360 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2008 | 765 | 0.060 |
Why?
|
Nutrition Assessment | 1 | 2008 | 723 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2064 | 0.060 |
Why?
|
Elasticity | 1 | 2006 | 657 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1525 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4931 | 0.060 |
Why?
|
Pregnancy | 4 | 2006 | 29140 | 0.060 |
Why?
|
Preoperative Care | 1 | 2012 | 2251 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2007 | 1342 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 1826 | 0.060 |
Why?
|
Skin Transplantation | 1 | 2008 | 1074 | 0.050 |
Why?
|
Postoperative Period | 1 | 2008 | 1841 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3617 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
Fluoroscopy | 1 | 2006 | 924 | 0.050 |
Why?
|
Species Specificity | 1 | 2006 | 2480 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8337 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1729 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8939 | 0.050 |
Why?
|
Implant Capsular Contracture | 1 | 2020 | 22 | 0.050 |
Why?
|
Adolescent | 6 | 2018 | 85729 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3608 | 0.050 |
Why?
|
Fat Necrosis | 1 | 2020 | 58 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2008 | 1738 | 0.050 |
Why?
|
Male | 9 | 2019 | 349776 | 0.040 |
Why?
|
Models, Animal | 1 | 2006 | 2172 | 0.040 |
Why?
|
Rats | 2 | 2007 | 24250 | 0.040 |
Why?
|
Femoral Artery | 1 | 2004 | 845 | 0.040 |
Why?
|
Risk Factors | 4 | 2016 | 72252 | 0.040 |
Why?
|
Child | 2 | 2023 | 77637 | 0.040 |
Why?
|
Anemia | 1 | 2008 | 1502 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1677 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2019 | 245 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1851 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 21733 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18027 | 0.040 |
Why?
|
Protons | 1 | 2022 | 1129 | 0.040 |
Why?
|
Insufflation | 1 | 2016 | 65 | 0.040 |
Why?
|
Smoking | 1 | 2013 | 8984 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2002 | 2649 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2015 | 11036 | 0.030 |
Why?
|
Age Factors | 2 | 2018 | 18355 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8300 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2004 | 1161 | 0.030 |
Why?
|
United States | 3 | 2022 | 69859 | 0.030 |
Why?
|
Oxygen | 1 | 2006 | 4189 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1262 | 0.030 |
Why?
|
Hematoma | 1 | 2019 | 758 | 0.030 |
Why?
|
Decision Trees | 1 | 2015 | 506 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1203 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2883 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1917 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1146 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2019 | 1009 | 0.030 |
Why?
|
Mammography | 1 | 2004 | 2475 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2879 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2018 | 975 | 0.020 |
Why?
|
Models, Economic | 1 | 2015 | 712 | 0.020 |
Why?
|
Cost Savings | 1 | 2015 | 925 | 0.020 |
Why?
|
Prognosis | 3 | 2015 | 29052 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1636 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3420 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2005 | 13028 | 0.020 |
Why?
|
Patient Compliance | 1 | 2019 | 2683 | 0.020 |
Why?
|
Length of Stay | 1 | 2022 | 6311 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1750 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8655 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12744 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10251 | 0.020 |
Why?
|
Signal Transduction | 1 | 2006 | 23398 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15211 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 20121 | 0.010 |
Why?
|